Literature DB >> 11292000

Dose relationship of limbic-cortical D2-dopamine receptor occupancy with risperidone.

F Yasuno1, T Suhara, Y Okubo, Y Sudo, M Inoue, T Ichimiya, S Tanada.   

Abstract

RATIONALE: It has been suggested that the antipsychotic effect of antipsychotics is mediated by the antagonism of the dopamine D2 receptor in the limbic-cortical regions. Risperidone has an atypical property, but its effect on limbic-cortical regions has not been evaluated.
OBJECTIVES: In this study, we examined the relationship among doses of risperidone and limbic-cortical dopamine D2 receptor occupancy using positron emission tomography.
METHODS: Seven patients with schizophrenia were scanned during the steady state with risperidone. Their occupancies in limbic-cortical regions were determined using positron emission tomography with [11C]FLB 457.
RESULTS: The average occupancy ranged from 38% to 80% on doses of 1-6 mg/day. The saturation curve plotted against the drug level fit the data well.
CONCLUSIONS: Our results demonstrate that the D2 receptor occupancy with risperidone in the limbic-cortical regions seems to be similar to that of previous reports regarding the striatum, and it would be comparable to that of typical antipsychotics.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11292000     DOI: 10.1007/s002130000643

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  7 in total

1.  Relationship between dose, drug levels, and D2 receptor occupancy for the atypical antipsychotics risperidone and paliperidone.

Authors:  E C Muly; J R Votaw; J Ritchie; L L Howell
Journal:  J Pharmacol Exp Ther       Date:  2012-01-03       Impact factor: 4.030

Review 2.  How antipsychotics work-from receptors to reality.

Authors:  Shitij Kapur; Ofer Agid; Romina Mizrahi; Ming Li
Journal:  NeuroRx       Date:  2006-01

3.  Extrastriatal dopamine D(2) receptor occupancy in olanzapine-treated patients with schizophrenia.

Authors:  Ryosuke Arakawa; Hiroshi Ito; Masaki Okumura; Akihiro Takano; Hidehiko Takahashi; Harumasa Takano; Yoshiro Okubo; Tetsuya Suhara
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-10-23       Impact factor: 5.270

4.  In vivo affinity of [18F]fallypride for striatal and extrastriatal dopamine D2 receptors in nonhuman primates.

Authors:  Mark Slifstein; Dah-Ren Hwang; Yiyun Huang; Ningning Guo; Yasuhiko Sudo; Raj Narendran; Peter Talbot; Marc Laruelle
Journal:  Psychopharmacology (Berl)       Date:  2004-09       Impact factor: 4.530

5.  Dose-finding study of paliperidone ER based on striatal and extrastriatal dopamine D2 receptor occupancy in patients with schizophrenia.

Authors:  Ryosuke Arakawa; Hiroshi Ito; Akihiro Takano; Hidehiko Takahashi; Takuya Morimoto; Takeshi Sassa; Katsuya Ohta; Motoichiro Kato; Yoshiro Okubo; Tetsuya Suhara
Journal:  Psychopharmacology (Berl)       Date:  2007-12-06       Impact factor: 4.530

6.  Central nervous system drug evaluation using positron emission tomography.

Authors:  Mizuho Sekine; Jun Maeda; Hitoshi Shimada; Tsuyoshi Nogami; Ryosuke Arakawa; Harumasa Takano; Makoto Higuchi; Hiroshi Ito; Yoshiro Okubo; Tetsuya Suhara
Journal:  Clin Psychopharmacol Neurosci       Date:  2011-04-30       Impact factor: 2.582

Review 7.  Current Understanding of the Neurobiology of Agitation.

Authors:  Christopher W T Miller; Vedrana Hodzic; Eric Weintraub
Journal:  West J Emerg Med       Date:  2020-07-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.